Arrhythmia News and Research

RSS

An arrhythmia is a problem with the speed or rhythm of the heartbeat. During an arrhythmia, the heart can beat too fast, too slow, or with an irregular rhythm. A heartbeat that is too fast is called tachycardia. A heartbeat that is too slow is called bradycardia. Most arrhythmias are harmless, but some can be serious or even life threatening. When the heart rate is too slow, too fast, or irregular, the heart may not be able to pump enough blood to the body. Lack of blood flow can damage the brain, heart, and other organs.

Rwanda, QIAGEN and Merck launch comprehensive national cervical cancer prevention program

The Government of Rwanda, together with QIAGEN N.V. and Merck, known as MSD outside the United States and Canada, today announced the launch, in Kigali, Rwanda, of a comprehensive national cervical cancer prevention program that includes vaccination with GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] for appropriate girls 12 to 15 years of age and modern molecular diagnostic screening for women between the ages of 35 and 45.

From QIAGEN Manchester Limited 25 Apr 2011

Novation adds BIOTRONIK to Cardiac Rhythm Management Devices portfolio

Novation, the leading health care supply contracting company, announced today the addition of BIOTRONIK (Lake Oswego, OR) to its Cardiac Rhythm Management (CRM) Devices portfolio. This new 30-month agreement represents the first collaboration between the respective organizations.

22 Apr 2011

Cardiologist pioneers new test to detect sudden death syndrome in young athletes

When a high school athlete drops dead, the rare but fatal condition called "sudden death syndrome" dominates the headlines. For reasons that remain a mystery to scientists, some young athletes - especially young males - begin to experience an unusual heart arrhythmia. With over-exertion, their hearts stop pumping, leading to sudden death.

22 Apr 2011

New nonviral method to create cardiac cells

Johns Hopkins scientists have developed a simplified, cheaper, all-purpose method they say can be used by scientists around the globe to more safely turn blood cells into heart cells. The method is virus-free and produces heart cells that beat with nearly 100 percent efficiency, they claim.

11 Apr 2011

Novation adds St. Jude Medical to portfolio of Cardiac Rhythm Management products

Novation, the leading health care supply contracting company, announced today the addition of St. Jude Medical (St. Paul, MN) to its portfolio of agreements for Cardiac Rhythm Management products.

8 Apr 2011

EKG test is a poor predictor of sudden death syndrome in young athletes

The sudden death of a young athlete always prompts full media attention, most recently spurring a call for preventative screening methods, including costly electrocardiogram tests for all school-age athletes.

6 Apr 2011

RE-LY trial results suggest Pradaxa capsule reduces risk of stroke in AF patients

Two new retrospective subanalyses of the RE-LY trial, involving Pradaxa capsules, suggested that the reduction in stroke risk achieved with PRADAXA 150mg over warfarin occurred irrespective of CHA2DS2-VASc risk score and the type of non-valvular atrial fibrillation.

5 Apr 2011

Abiomed presents Impella PROTECT II study final results in PCI at ACC and i2 Summit

Abiomed, Inc., a leading provider of breakthrough heart support technologies, today announced the final results from the PROTECT II study, presented by William O'Neill, M.D., Dean of University of Miami and Principal Investigator of PROTECT II, at the American College of Cardiology's 60th Annual Scientific Session and i2 Summit 2011 in New Orleans.

4 Apr 2011

Merck's VICTRELIS phase III study results against HCV presented at EASL annual meeting

Merck, known as MSD outside of the United States and Canada, announced results from several new data analyses from the pivotal Phase III studies evaluating the addition of its investigational oral protease inhibitor VICTRELIS to peginterferon alfa-2b and ribavirin in adult patients with chronic hepatitis C virus genotype 1 infection.

1 Apr 2011

Study finds frequent anaemia in patients with chronic respiratory failure

A study of nearly 600 patients with severe non-inflammatory respiratory disease has found that a significant percentage also suffered from anaemia, according to the April issue of IJCP, the International Journal of Clinical Practice.

31 Mar 2011

Electrophysiologists use new robotic system to treat cardiac arrhythmias

Cardiac experts who fix arrhythmias, which are electrical problems of the heart, must perform complex catheter procedures while the heart is still beating in order to pinpoint where an electrical malfunction is taking place.

31 Mar 2011

BIOTRONIK completes patient enrollment in IN-TIME clinical trial to treat HF

BIOTRONIK SE & Co. KG, a leading manufacturer of cardiac devices, announced today that the last chronic heart failure patient was enrolled in IN-TIME at the Schwabing Clinic in Munich, Germany, with principle investigator Professor Stefan Sack, MD.

30 Mar 2011

New guidelines highlight genetic testing use in heart arrhythmia clinical management

The Canadian Cardiovascular Society and Canadian Heart Rhythm Society have produced the first-ever comprehensive guidelines on the use of genetic testing in the clinical management of inherited heart rhythm disorders, released in the March/April issue of the Canadian Journal of Cardiology published by Elsevier.

29 Mar 2011

Study links specific cardiovascular risk factors to AF episodes

Reducing cardiovascular risk factors like high blood pressure, smoking, diabetes and being overweight could potentially reduce more than half of all cases of atrial fibrillation, according to research reported in Circulation: Journal of the American Heart Association.

29 Mar 2011

FDA approves Medtronic's Protecta implantable defibrillators

Medtronic, Inc. today announced U.S. Food and Drug Administration approval of the Protecta portfolio of implantable cardioverter-defibrillators and cardiac resynchronization therapy-defibrillators.

29 Mar 2011

FDA approves Medtronic's Consulta and Syncra pacemaker systems

Medtronic, Inc. today announced that the U.S. Food & Drug Administration has approved its Consulta and Syncra cardiac resynchronization therapy-pacemaker systems.

25 Mar 2011

First MRI-compatible pacemaker implanted in patient at MetroSouth Medical Center

Lee Ryan, 74, a Worth, Illinois man was among the first in Chicago to receive a MRI-compatible pacemaker. His pacemaker was implanted at MetroSouth Medical Center, a hospital known for its excellent cardiac care.

24 Mar 2011

Dabigatran etexilate cost-effective compared to current care for stroke prevention in AF patients

A new health economic analysis, published today online in Thrombosis and Haemostasis, suggested that Boehringer Ingelheim's novel oral direct thrombin inhibitor, dabigatran etexilate, is cost-effective compared to current treatment options, particularly in "real-world" clinical practice.

23 Mar 2011

STJ inaugurates Advanced Technology Center for physicians in Beijing

St. Jude Medical, Inc., a global medical device company, today celebrated the grand opening of the St. Jude Medical Advanced Technology Center Asia Pacific, located in Beijing, China.

22 Mar 2011

Sports medicine physician suggests cardiac screening for young athletes requires augmentation of existing diagnostics to achieve greater accuracy, become cost-effective

Sports medicine physician Steve Watts says cardiac screening for young athletes is useful in preventing sudden cardiac death and suggests new diagnostics have the potential to add value and change the debate about the viability of cardiac screening for young athletes in the United States.

17 Mar 2011

Arrhythmia News and Research

Rwanda, QIAGEN and Merck launch comprehensive national cervical cancer prevention program

Novation adds BIOTRONIK to Cardiac Rhythm Management Devices portfolio

Cardiologist pioneers new test to detect sudden death syndrome in young athletes

New nonviral method to create cardiac cells

Novation adds St. Jude Medical to portfolio of Cardiac Rhythm Management products

EKG test is a poor predictor of sudden death syndrome in young athletes

RE-LY trial results suggest Pradaxa capsule reduces risk of stroke in AF patients

Abiomed presents Impella PROTECT II study final results in PCI at ACC and i2 Summit

Merck's VICTRELIS phase III study results against HCV presented at EASL annual meeting

Study finds frequent anaemia in patients with chronic respiratory failure

Electrophysiologists use new robotic system to treat cardiac arrhythmias

BIOTRONIK completes patient enrollment in IN-TIME clinical trial to treat HF

New guidelines highlight genetic testing use in heart arrhythmia clinical management

Study links specific cardiovascular risk factors to AF episodes

FDA approves Medtronic's Protecta implantable defibrillators

FDA approves Medtronic's Consulta and Syncra pacemaker systems

First MRI-compatible pacemaker implanted in patient at MetroSouth Medical Center

Dabigatran etexilate cost-effective compared to current care for stroke prevention in AF patients

STJ inaugurates Advanced Technology Center for physicians in Beijing

Sports medicine physician suggests cardiac screening for young athletes requires augmentation of existing diagnostics to achieve greater accuracy, become cost-effective

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News